Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001253446 | SCV001429154 | pathogenic | Developmental and epileptic encephalopathy, 7 | 2016-06-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003588564 | SCV004354111 | pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2023-07-03 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 21759). This variant is also known as 1369del2. This premature translational stop signal has been observed in individual(s) with KCNQ2-related conditions (PMID: 15030501). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys398Glufs*2) in the KCNQ2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNQ2 are known to be pathogenic (PMID: 14534157, 23692823, 27779742). |
Gene |
RCV000678055 | SCV000041610 | not provided | Seizures, benign familial neonatal, 1 | no assertion provided | literature only | BFNIS (benign familial neonatal-infantile seizures) |